HIV kicked out: Fundament for a new therapy established

A complete cure from an HIV-infection is currently not available. At present, lifelong treatment regimes are required to block the outbreak of AIDS, and these treatments do not eliminate the integrated provirus from infected cells. Now, scientists from the Heinrich-Pette-Institute for Experimental Virology and Immunology (HPI) in Hamburg and the Max-Planck-Institute of Molecular Cell Biology und Genetics in Dresden (MPI-CBG) have developed an enzyme that specifically cuts out the viral genome and eradicates the virus from the host cell. (Science, June, 29th 2007)

HIV introduces its genetic material into the DNA of body cells permanently. In particular, the immune cells are doomed due to the production of new viruses. The teams of Joachim Hauber from the HPI and Frank Buchholz from the MPI-CBG have now succeeded in specifically removing the viral DNA from infected cells. “We got rid of the virus from the infected cells; nobody has done this before”, the scientists commented.

To achieve this result they genetically engineered a recombinase, an enzyme that works like molecular scissors. Recombinases cut and paste DNA sequences at specific sites. “Naturally occurring recombinases do not recognize viral sequences and are therefore not useful for an anti-viral approach”, said Buchholz: “So we had to develop a recombinase that recognizes the viral sequence and removes the virus with precision.”

The molecular biologists started from a recombinase that naturally is found in a bacteriophage. This enzyme, termed “Cre”, does not recognize sequences from the HIV genome. Using the forces of evolution the scientists used more than 120 generation cycles to breed the enzyme “Tre”, which is now able to recognize HIV sequences.

“Although Tre has so far only been tested in tissue culture cells, this work lays the technical foundation for a novel therapeutic approach that one day might be used to eradicate the HIV from cells of infected patients” said Hauber. However, it is still a long way until this approach can be used in clinical practice. “We will first go back to the bench to further improve the enzyme and then test whether the recombinase can be delivered efficiently and safely to cells in the human body”, said Buchholz and Hauber.

Original publication
Indrani Sarkar, Ilona Hauber, Joachim Hauber, Frank Buchholz
HIV-1 Proviral DNA Excision Using an Evolved Recombinase
Science, June, 29th, 2007
Further information can be obtained from:
Dr. Frank Buchholz
Max-Planck-Institut für Molekulare Zellbiologie und Genetik, Dresden
E-Mail: buchholz@mpi-cbg.de
Prof. Dr. Joachim Hauber
Heinrich-Pette-Institut für Experimentelle Virologie und Immunologie, Hamburg
E-Mail: joachim.hauber@hpi.uni-hamburg.de

Media Contact

Dr. Angela Homfeld idw

All latest news from the category: Life Sciences and Chemistry

Articles and reports from the Life Sciences and chemistry area deal with applied and basic research into modern biology, chemistry and human medicine.

Valuable information can be found on a range of life sciences fields including bacteriology, biochemistry, bionics, bioinformatics, biophysics, biotechnology, genetics, geobotany, human biology, marine biology, microbiology, molecular biology, cellular biology, zoology, bioinorganic chemistry, microchemistry and environmental chemistry.

Back to home

Comments (0)

Write a comment

Newest articles

RNA-binding protein RbpB regulating gut microbiota metabolism in Bacteroides thetaiotaomicron.

Trust Your Gut—RNA-Protein Discovery for Better Immunity

HIRI researchers uncover control mechanisms of polysaccharide utilization in Bacteroides thetaiotaomicron. Researchers at the Helmholtz Institute for RNA-based Infection Research (HIRI) and the Julius-Maximilians-Universität (JMU) in Würzburg have identified a…

Microscopic view of blood cells representing ASXL1 mutation research findings.

ASXL1 Mutation: The Hidden Trigger Behind Blood Cancers and Inflammation

Scientists show how a mutated gene harms red and white blood cells. LA JOLLA, CA—Scientists at La Jolla Institute for Immunology (LJI) have discovered how a mutated gene kicks off…

Diagram of lithium titanium phosphate crystal lattice structure showing its negative thermal expansion properties for enhanced lithium-ion battery performance.

Recharging the Future: Batteries Built for Extreme Cold Using Negative Thermal Expansion

Most solids expand as temperatures increase and shrink as they cool. Some materials do the opposite, expanding in the cold. Lithium titanium phosphate is one such substance and could provide…